Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD Biogen Inc. Transaction History
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD
- $1.21 Billion
- Q4 2024
A detailed history of Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD transactions in Biogen Inc. stock. As of the latest transaction made, Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD holds 54,585 shares of BIIB stock, worth $7.78 Million. This represents 0.69% of its overall portfolio holdings.
Number of Shares
54,585Holding current value
$7.78 Million% of portfolio
0.69%Shares
1 transactions
Others Institutions Holding BIIB
# of Institutions
993Shares Held
130MCall Options Held
1.12MPut Options Held
1.43M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.38 Billion0.06% of portfolio
-
Primecap Management CO Pasadena, CA16MShares$2.29 Billion1.94% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.07 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.34MShares$1.05 Billion0.06% of portfolio
-
Jpmorgan Chase & CO New York, NY5.26MShares$749 Million0.08% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $20.5B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...